Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR2 | P50052 | 5/20 | 0.62 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.62 |
| ▸ | REN | P00797 | 2/20 | 0.57 |
| ▸ | NPY2R | P49146 | 6/20 | 0.54 |
| ▸ | NPY4R | P50391 | 6/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.54 |
| ▸ | NPY1R | P25929 | 4/20 | 0.54 |
| ▸ | TFPI | P10646 | 6/20 | 0.54 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.53 |
| ▸ | CALCR | P30988 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Angiotensin Amide SCHEMBL9324 | 0.90 | AGTR2 (0.74) | AGTR2AGTR1RENNPY2RNPY4R | |
| Angiotensin Amide SCHEMBL8155919 | 0.90 | AGTR2 (0.74) | AGTR2AGTR1RENNPY2RNPY4R | |
| Angiotensin Amide SCHEMBL7337886 | 0.89 | AGTR2 (0.73) | AGTR2AGTR1RENNPY2RNPY4R | |
| Angiotensin Amide SCHEMBL9433448 | 0.89 | AGTR2 (0.73) | AGTR2AGTR1RENNPY2RNPY4R | |
| Angiotensin Amide SCHEMBL2197068 | 0.89 | AGTR2 (0.73) | AGTR2AGTR1RENNPY2RNPY4R | |
| Angiotensin Amide SCHEMBL5722115 | 0.88 | AGTR2 (0.75) | AGTR2AGTR1RENNPY2RNPY4R | |
| Angiotensin Amide SCHEMBL10495835 | 0.88 | AGTR2 (0.72) | AGTR2AGTR1RENNPY2RNPY4R | |
| Angiotensin Amide SCHEMBL23015107 | 0.88 | AGTR2 (0.71) | AGTR2AGTR1RENNPY2RNPY4R | |
| Angiotensin Amide SCHEMBL3850850 | 0.88 | AGTR2 (0.71) | AGTR2AGTR1RENNPY2RNPY4R | |
| Angiotensin Ii SCHEMBL513519 | 0.86 | AGTR2 (0.82) | AGTR2AGTR1RENNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1086217-A2 | NOVEL ANGIOTENSIN RECEPTOR, PRODUCTION AND USE THEREOF | Aventis Pharma Deutschland GmbH (DE) | 2001-03-28 | — | — | EP | disclosed |
| EP-1086217-A2 | NOVEL ANGIOTENSIN RECEPTOR, PRODUCTION AND USE THEREOF | Aventis Pharma Deutschland GmbH (DE) | 2001-03-28 | — | — | EP | disclosed |
| WO-1999064585-A3 | NOVEL ANGIOTENSIN RECEPTOR, PRODUCTION AND USE THEREOF | AVENTIS PHARMA GMBH (DE) | 2000-04-06 | — | — | WO | disclosed |
| WO-1999064585-A2 | NOVEL ANGIOTENSIN RECEPTOR, PRODUCTION AND USE THEREOF | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999064585-A2 | NOVEL ANGIOTENSIN RECEPTOR, PRODUCTION AND USE THEREOF | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 1999-12-16 | — | — | WO | disclosed |